Morepen starts commercial supplies under its Rs. 825 crore CDMO mandate

Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced ₹825 crore CDMO mandate. The first commercial dispatch, valued at approximately ₹50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation and qualification stage to commercial execution stage.

Commenting on the development, Mr. Sanjay Suri, Managing Director, Morepen Laboratories Limited, said, "This is an important milestone in Morepen's transition toward long-duration global manufacturing partnerships. Our teams have worked closely with the customer through validation, manufacturing readiness and supply-chain planning. Having started execution of commercial supplies, we are focused on scaling up, expanding capacity and building a stronger CDMO platform across additional customer and product opportunities."

Having dispatched the first batch under the CDMO mandate, Morepen expects to scale the program further in the coming quarter, with additional supplies of approximately ₹225 crore expected during Q2FY2026-27, subject to customer schedules and regulatory/commercial requirements.

The Company continues to strengthen its manufacturing infrastructure to support larger CDMO opportunities. Total reactor capacity is expected to reach approximately 600 KL by the end of Q2, followed by further expansion toward 800 KL and 1,000 KL in subsequent phases.

The commencement of commercial supplies under this mandate reinforces Morepen's strategy to build a scalable CDMO platform, deepen customer partnerships and participate in long-duration global manufacturing opportunities.

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 59.15 as compared to the previous close of Rs. 54.62. The total number of shares traded during the day was 2759568 in over 7975 trades.

The stock hit an intraday high of Rs. 60.50 and intraday low of 55.05. The net turnover during the day was Rs. 161929389.00.

Source : Equity Bulls

Keywords

MorepenLaboratories INE083A01026 Pharmaceuticals CDMOMandate CommercialSupplies